Please login to order a test.
X-linked Lymphoproliferative Disease (XLP): SH2D1A (Full Gene Sequencing)
Confirm a clinical diagnosis of XLP; detect carriers; allow early diagnosis in family members
This method does not reliably detect mosaic variants; large deletions; large duplications, inversions, or other rearrangements; or deep intronic variants. It may be affected by allele-dropout, it may not allow determination of the exact numbers of T/A or microsatellite repeats, and it does not allow any conclusion as to whether two heterozygous variants are present on the same or on different chromosome copies.
Results of this test are for investigational purposes only. The performance characteristics of this assay have been determined by LabCorp. The result should not be used as a diagnostic procedure without confirmation of the diagnosis by another medically established diagnostic product or procedure.
Normal equals reference sequence or variants that are known or predicted to be benign; abnormal equals all other variants.
X-linked lymphoproliferative disease (XLP), also known as Duncan's disease, is an X-linked recessive immune disorder characterized by fulminant infectious mononucleosis (FIM), dysgammaglobulinemia, and/or lymphoproliferative disorders. FIM, which occurs in response to infection with Epstein-Barr virus, affects approximately 60% of XLP patients and is the most severe manifestation, often leading to death within one to two months. Dysgammaglobulinemia affects about 30% of patients, and malignant and nonmalignant lymphomas occur in 20% to 30% of XLP patients. To date, mutations in SH2D1A are the only known cause of XLP. Genetic testing can confirm a clinical diagnosis of XLP and detect mutation carriers within affected families.
Whole blood; DNA is accepted (Call 800-345-4363 for DNA collection information.)
Samples may be stored for brief periods at 4°C. Ship overnight at room temperature.
Causes for Rejection
In cases in which a known mutation can be documented, the physician may prefer to order test 252740.
Test orders must include an attestation that the provider has the patient's informed consent for genetic testing. See sample physician office consent form: Consent for Genetic Testing. In the case of family tests (ie, known mutations), please submit the result report of the first patient tested in the family (the index case), if not performed at a LabCorp facility. Other family members are subsequently tested for the specific mutation found in the first patient tested.
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|